Stocks and Investing
Stocks and Investing
Tue, November 9, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Steven Seedhouse Maintained (APLS) at Strong Buy with Increased Target to $116 on, Nov 9th, 2021
Steven Seedhouse of Raymond James, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $102 to $116 on, Nov 9th, 2021.
Steven has made no other calls on APLS in the last 4 months.
There are 6 other peers that have a rating on APLS. Out of the 6 peers that are also analyzing APLS, 2 agree with Steven's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Downgraded from Buy to Hold and Decreased Target to $39 on, Friday, September 10th, 2021
- Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $38 on, Friday, September 10th, 2021
These are the ratings of the 4 analyists that currently disagree with Steven
- Elemer Piros of "Roth Capital" Maintained at Strong Buy with Decreased Target to $46 on, Friday, September 10th, 2021
- Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $70 on, Friday, September 10th, 2021
- Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $69 on, Friday, September 10th, 2021
- Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $74 on, Thursday, August 19th, 2021
Contributing Sources